Atyr Pharma, Inc.
Records under this name other than the patents Atyr Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 73 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,753,638 | Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities now held by Pangu Biopharma Limited In force · High confidence | In force | High confidence | |
| US 9,605,265 | Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities now held by Pangu Biopharma Limited In force · High confidence | In force | High confidence | |
| US 10,017,582 | Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities now held by Pangu Biopharma Limited In force · High confidence | In force | High confidence | |
| US 10,526,419 | Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities now held by Pangu Biopharma Limited In force · High confidence | In force | High confidence | |
| US 10,941,214 | Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities now held by Pangu Biopharma Limited In force · High confidence | In force | High confidence | |
| US 11,078,299 | Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities now held by Pangu Biopharma Limited In force · High confidence | In force | High confidence | |
| US 12,497,466 | Compositions and Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities now held by Pangu Biopharma Limited In force · High confidence | In force | High confidence | |
| US 8,835,387 | Histidyl-Trna Synthetases for Treating Autoimmune and Inflammatory Diseases Lapsed on the fee record Ended Sep 16, 2026 · High confidence | Lapsed on the fee record | Ended Sep 16, 2026 | High confidence |
| US 10,030,077 | Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Cysteinyl-Trna Synthetase Lapsed on the fee record Ended Jul 24, 2026 · High confidence | Lapsed on the fee record | Ended Jul 24, 2026 | High confidence |
| US 9,540,628 | Aminoacyl Trna Synthetases for Modulating Inflammation Lapsed on the fee record Ended Jan 10, 2025 · High confidence | Lapsed on the fee record | Ended Jan 10, 2025 | High confidence |